Clinical Trial Update: Efficacy of QAX576 in Asthma [Phase 2]

View source ↗

Summary

Phase 2 trial results for QAX576 in asthma have been completed, reporting efficacy outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• QAX576

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Asthma | Phase 2 | Status: COMPLETED